The Myasthenia Gravis Program offers comprehensive diagnostic evaluation, consultation, treatment, and management for patients with myasthenia gravis (MG) from around the world. We are one of the largest programs in the Northeast United States and are dedicated to excellent patient care, as well as pursuing new approaches in treatment through translational research.

Our doctors and researchers are among the nation’s experts in rare neuromuscular diseases such as myasthenia gravis and Lambert-Eaton myasthenic syndrome (LEMS). These diseases are characterized by muscle weakness caused by disturbances in the normal communication between nerves and muscles.